(Q44112135)

29 November 2017

Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia (English)

1 reference

29 November 2017

0 references

1 reference

Kaiser R

1

1 reference

29 November 2017

Tremblay PB

2

1 reference

29 November 2017

Klufmöller F

3

1 reference

29 November 2017

Roots I

4

1 reference

29 November 2017

Brockmöller J

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

29 November 2017

1 reference

29 November 2017

7

1 reference

29 November 2017

695-705

1 reference

29 November 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001054

29 November 2017

0 references

cites work

Pharmacological profile of HWA-131, a novel antiinflammatory agent with immunomodulating properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Dopamine receptors and brain function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Effects of specific dopamine D1 and D2 receptor antagonists and agonists and neuroleptic drugs on emotional defecation in a rat model of akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Adverse neurobiological effects of long-term use of neuroleptics: human and animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Cloning of the cDNA and gene for a human D2 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Analysis of the Structure and Expression of the Human Dopamine D2AReceptor Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Functional analysis of the human D2 dopamine receptor missense variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Akathisia: a comprehensive review and treatment summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

-141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Dopamine DRD2/Cys311 is not associated with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Homozygosity for the Gly-9 variant of the dopamine D3 receptor and risk for tardive dyskinesia in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Dopamine D2 receptor molecular variant and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

Reversible drug-induced parkinsonism. Clinicopathologic study of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Physiologic and clinical effects of chlorpromazine and their relationship to plasma level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Analysis of neuroleptic binding affinities and potencies for the different human D2 dopamine receptor missense variants.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Association of dopamine D2 receptor molecular variant with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Dopamine D2 receptor promoter polymorphism: no association with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

European multicentre association study of schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001054

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001054

1 reference

29 November 2017

1 reference